Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm

Immunobiology

Volumn 220, Issue 2, 2015, Pages 200-209

  Zheng, Fang ^a,b,c   Devoogdt, Nick ^a   Sparkes, Amanda ^a,b   Morias, Yannick ^a,b   Abels, Chloé ^a,b   Stijlemans, Benoit ^a,b   Lahoutte, Tony ^a,d   Muyldermans, Serge ^a   De Baetselier, Patrick ^a,b   Schoonooghe, Steve ^a,b   Beschin, Alain ^a,b   Raes, Geert ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Complement receptor of the Ig superfamily (CRIg); Concanavalin A (ConA); Hepatitis; Kupffer cells; Nanobody; SPECT CT; V set and immunoglobulin domain containing 4 (Vsig4)

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 6; MACROPHAGE MANNOSE RECEPTOR; MANNOSE RECEPTOR; NANOBODY; PLASMA PROTEIN; TECHNETIUM 99M; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; V SET AND IMMUNOGLOBULIN DOMAIN CONTAINING 4 PROTEIN; ANTIGEN; CD11B ANTIGEN; COMPLEMENT RECEPTOR; CRIG PROTEIN, MOUSE; CYTOKINE; MEMBRANE ANTIGEN;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DEPLETION; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ACUTE DISEASE; ANIMAL; CELL COUNT; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION; GENETICS; HEPATITIS A; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PHENOTYPE;

ACUTE DISEASE; ANIMALS; ANTIGENS; ANTIGENS, CD11B; ANTIGENS, SURFACE; CELL COUNT; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEPATITIS A; IMMUNOPHENOTYPING; KUPFFER CELLS; MALE; MICE; MOLECULAR IMAGING; PHENOTYPE; RECEPTORS, COMPLEMENT; SINGLE-DOMAIN ANTIBODIES;

EID: 84977781771     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.09.018     Document Type: Article

References (30)

1. Barth M.W., Hendrzak J.A., Melnicoff M.J., Morahan P.S. Review of the macrophage disappearance reaction. J. Leukoc. Biol. 1995, 57:361-367.
2. Bieze M., Klumpen H.J., Verheij J., Beuers U., Phoa S.S., van Gulik T.M., Bennink R.J. Diagnostic accuracy of (18)F-methylcholine positron emission tomography/computed tomography for intra- and extrahepatic hepatocellular carcinoma. Hepatology 2014, 59:996-1006.
3. Bilzer M., Roggel F., Gerbes A.L. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006, 26:1175-1186.
4. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14:986-995.
5. De Vos J., Devoogdt N., Lahoutte T., Muyldermans S. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target. Expert Opin. Biol. Ther. 2013, 13:1149-1160.
6. Delbeke D., Pinson C.W. 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J. Nucl. Med. 2003, 44:222-223.
7. Devey L., Ferenbach D., Mohr E., Sangster K., Bellamy C.O., Hughes J., Wigmore S.J. Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol. Ther. 2009, 17:65-72.
8. Gainkam L.O., Caveliers V., Devoogdt N., Vanhove C., Xavier C., Boerman O., Muyldermans S., Bossuyt A., Lahoutte T. Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice. Contrast Media Mol. Imaging 2011, 6:85-92.
9. Garin E., Rolland Y., Lenoir L., Pracht M., Mesbah H., Poree P., Laffont S., Clement B., Raoul J.L., Boucher E. Utility of quantitative Tc-MAA SPECT/CT for yttrium-labelled microsphere treatment planning: calculating vascularized hepatic volume and dosimetric approach. Int. J. Mol. Imaging 2011, 2011:398051.
10. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., Mazloom A.R., Ma'ayan A., Chua W.J., Hansen T.H., Turley S.J., Merad M., Randolph G.J. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
11. Guo S., Yang C., Mei F., Wu S., Luo N., Fei L., Chen Y., Wu Y. Down-regulation of Z39Ig on macrophages by IFN-gamma in patients with chronic HBV infection. Clin. Immunol. 2010, 136:282-291.
12. He J.Q., Wiesmann C., van Lookeren Campagne M. A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol. Immunol. 2008, 45:4041-4047.
13. Helmy K.Y., Katschke K.J., Gorgani N.N., Kljavin N.M., Elliott J.M., Diehl L., Scales S.J., Ghilardi N., van Lookeren Campagne M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006, 124:915-927.
14. Ikarashi M., Nakashima H., Kinoshita M., Sato A., Nakashima M., Miyazaki H., Nishiyama K., Yamamoto J., Seki S. Distinct development and functions of resident and recruited liver Kupffer cells/macrophages. J. Leukoc. Biol. 2013, 94:1325-1336.
15. Jenne C.N., Kubes P. Immune surveillance by the liver. Nat. Immunol. 2013, 14:996-1006.
16. Klein I., Cornejo J.C., Polakos N.K., John B., Wuensch S.A., Topham D.J., Pierce R.H., Crispe I.N. Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007, 110:4077-4085.
17. Malovic I., Sorensen K.K., Elvevold K.H., Nedredal G.I., Paulsen S., Erofeev A.V., Smedsrod B.H., McCourt P.A. The mannose receptor on murine liver sinusoidal endothelial cells is the main denatured collagen clearance receptor. Hepatology 2007, 45:1454-1461.
18. Movahedi K., Schoonooghe S., Laoui D., Houbracken I., Waelput W., Breckpot K., Bouwens L., Lahoutte T., De Baetselier P., Raes G., Devoogdt N., Van Ginderachter J.A. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Res. 2012, 72:4165-4177.
19. 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. Nucl. Med. Commun. 2003, 24:809-817.
20. Pak K., Kim S.J., Kim I.J., Kim B.H., Kim S.S., Jeon Y.K. The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery. Endocr. Relat. Cancer 2013, 20:R203-R213.
21. Put S., Schoonooghe S., Devoogdt N., Schurgers E., Avau A., Mitera T., D'Huyvetter M., De Baetselier P., Raes G., Lahoutte T., Matthys P. SPECT imaging of joint inflammation with nanobodies targeting the macrophage mannose receptor in a mouse model for rheumatoid arthritis. J. Nucl. Med. 2013, 54:807-814.
22. Schoonooghe S., Laoui D., Van Ginderachter J.A., Devoogdt N., Lahoutte T., De Baetselier P., Raes G. Novel applications of nanobodies for in vivo bio-imaging of inflamed tissues in inflammatory diseases and cancer. Immunobiology 2012, 217:1266-1272.
23. Schumann J., Wolf D., Pahl A., Brune K., Papadopoulos T., van Rooijen N., Tiegs G. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am. J. Pathol. 2000, 157:1671-1683.
24. Tanaka M., Nagai T., Tsuneyoshi Y., Sunahara N., Matsuda T., Nakamura T., Tsuyama S., Hasui K., FitzGerald O., Matsuyama T. Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer. Clin. Exp. Immunol. 2008, 154:38-47.
25. Vaneycken I., D'Huyvetter M., Hernot S., De Vos J., Xavier C., Devoogdt N., Caveliers V., Lahoutte T. Immuno-imaging using nanobodies. Curr. Opin. Biotechnol. 2011, 22:877-881.
26. Vincke C., Loris R., Saerens D., Martinez-Rodriguez S., Muyldermans S., Conrath K. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J. Biol. Chem. 2009, 284:3273-3284.
27. Vogt L., Schmitz N., Kurrer M.O., Bauer M., Hinton H.I., Behnke S., Gatto D., Sebbel P., Beerli R.R., Sonderegger I., Kopf M., Saudan P., Bachmann M.F. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J. Clin. Invest. 2006, 116:2817-2826.
28. Wang H.X., Liu M., Weng S.Y., Li J.J., Xie C., He H.L., Guan W., Yuan Y.S., Gao J. Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J. Gastroenterol. 2012, 18:119-125.
29. Xie L., Yui J., Hatori A., Yamasaki T., Kumata K., Wakizaka H., Yoshida Y., Fujinaga M., Kawamura K., Zhang M.R. Translocator protein (18kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease. J. Hepatol. 2012, 57:1076-1082.
30. Zheng F., Put S., Bouwens L., Lahoutte T., Matthys P., Muyldermans S., De Baetselier P., Devoogdt N., Raes G., Schoonooghe S. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis. J. Nucl. Med. 2014, 55:824-829.